nodes	percent_of_prediction	percent_of_DWPC	metapath
Loperamide—POMC—locus ceruleus—narcolepsy	0.156	0.277	CbGeAlD
Loperamide—POMC—autonomic nervous system—narcolepsy	0.0827	0.147	CbGeAlD
Loperamide—CALM2—pons—narcolepsy	0.0245	0.0435	CbGeAlD
Loperamide—CALM1—pons—narcolepsy	0.0244	0.0433	CbGeAlD
Loperamide—CALM1—autonomic nervous system—narcolepsy	0.0225	0.04	CbGeAlD
Loperamide—POMC—brainstem—narcolepsy	0.02	0.0355	CbGeAlD
Loperamide—POMC—forebrain—narcolepsy	0.0193	0.0342	CbGeAlD
Loperamide—CACNA1A—brainstem—narcolepsy	0.0191	0.0339	CbGeAlD
Loperamide—CACNA1A—forebrain—narcolepsy	0.0184	0.0327	CbGeAlD
Loperamide—POMC—medulla oblongata—narcolepsy	0.0139	0.0247	CbGeAlD
Loperamide—CACNA1A—medulla oblongata—narcolepsy	0.0133	0.0236	CbGeAlD
Loperamide—POMC—midbrain—narcolepsy	0.0127	0.0226	CbGeAlD
Loperamide—OPRD1—forebrain—narcolepsy	0.0106	0.0189	CbGeAlD
Loperamide—OPRK1—forebrain—narcolepsy	0.0102	0.0181	CbGeAlD
Loperamide—POMC—brain—narcolepsy	0.008	0.0142	CbGeAlD
Loperamide—CACNA1A—brain—narcolepsy	0.00764	0.0136	CbGeAlD
Loperamide—OPRM1—brainstem—narcolepsy	0.00752	0.0134	CbGeAlD
Loperamide—OPRM1—forebrain—narcolepsy	0.00726	0.0129	CbGeAlD
Loperamide—CALM2—brainstem—narcolepsy	0.00546	0.00969	CbGeAlD
Loperamide—CALM1—brainstem—narcolepsy	0.00543	0.00965	CbGeAlD
Loperamide—CALM2—forebrain—narcolepsy	0.00527	0.00935	CbGeAlD
Loperamide—CALM1—forebrain—narcolepsy	0.00524	0.00931	CbGeAlD
Loperamide—CALM3—medulla oblongata—narcolepsy	0.00484	0.00861	CbGeAlD
Loperamide—OPRM1—midbrain—narcolepsy	0.00479	0.00851	CbGeAlD
Loperamide—CALM3—midbrain—narcolepsy	0.00443	0.00787	CbGeAlD
Loperamide—OPRD1—brain—narcolepsy	0.00441	0.00784	CbGeAlD
Loperamide—OPRK1—brain—narcolepsy	0.00423	0.00752	CbGeAlD
Loperamide—CALM2—medulla oblongata—narcolepsy	0.0038	0.00676	CbGeAlD
Loperamide—CALM1—medulla oblongata—narcolepsy	0.00379	0.00673	CbGeAlD
Loperamide—CALM2—midbrain—narcolepsy	0.00348	0.00618	CbGeAlD
Loperamide—CALM1—midbrain—narcolepsy	0.00346	0.00615	CbGeAlD
Loperamide—CYP2D6—brainstem—narcolepsy	0.00301	0.00535	CbGeAlD
Loperamide—OPRM1—brain—narcolepsy	0.00301	0.00535	CbGeAlD
Loperamide—CYP2D6—forebrain—narcolepsy	0.00291	0.00517	CbGeAlD
Loperamide—CALM3—brain—narcolepsy	0.00278	0.00494	CbGeAlD
Loperamide—CALM2—brain—narcolepsy	0.00219	0.00388	CbGeAlD
Loperamide—CALM1—brain—narcolepsy	0.00217	0.00386	CbGeAlD
Loperamide—ABCB1—forebrain—narcolepsy	0.00209	0.00372	CbGeAlD
Loperamide—CYP2C8—brain—narcolepsy	0.00181	0.00322	CbGeAlD
Loperamide—CYP2B6—brain—narcolepsy	0.00162	0.00289	CbGeAlD
Loperamide—ABCB1—medulla oblongata—narcolepsy	0.00151	0.00269	CbGeAlD
Loperamide—ABCB1—midbrain—narcolepsy	0.00138	0.00245	CbGeAlD
Loperamide—CYP2D6—brain—narcolepsy	0.00121	0.00214	CbGeAlD
Loperamide—OPRM1—GPCR ligand binding—HCRT—narcolepsy	0.00108	0.00247	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00107	0.00246	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00105	0.00241	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00105	0.00241	CbGpPWpGaD
Loperamide—CALM3—Cellular roles of Anthrax toxin—TNF—narcolepsy	0.00105	0.00239	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—TAC1—narcolepsy	0.00104	0.00237	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—NPS—narcolepsy	0.00104	0.00237	CbGpPWpGaD
Loperamide—CALM2—Cellular roles of Anthrax toxin—TNF—narcolepsy	0.00101	0.00232	CbGpPWpGaD
Loperamide—CALM1—Cellular roles of Anthrax toxin—TNF—narcolepsy	0.00101	0.00232	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—HCRTR2—narcolepsy	0.001	0.00229	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—HCRTR1—narcolepsy	0.001	0.00229	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—PENK—narcolepsy	0.000992	0.00227	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—P2RY11—narcolepsy	0.000969	0.00222	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—TRH—narcolepsy	0.000968	0.00222	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—HRH3—narcolepsy	0.000968	0.00222	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—PENK—narcolepsy	0.000963	0.0022	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000942	0.00216	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000924	0.00211	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000924	0.00211	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HCRTR2—narcolepsy	0.000911	0.00208	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HCRTR1—narcolepsy	0.000911	0.00208	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—P2RY11—narcolepsy	0.00088	0.00201	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000879	0.00201	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000879	0.00201	CbGpPWpGaD
Loperamide—ABCB1—brain—narcolepsy	0.000868	0.00154	CbGeAlD
Loperamide—OPRK1—GPCR downstream signaling—P2RY11—narcolepsy	0.000849	0.00194	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—HRH3—narcolepsy	0.000849	0.00194	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.000848	0.00194	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TRH—narcolepsy	0.000844	0.00193	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—HCRT—narcolepsy	0.000824	0.00188	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—TRH—narcolepsy	0.000818	0.00187	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—TAC1—narcolepsy	0.000802	0.00184	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—NPS—narcolepsy	0.000802	0.00184	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HCRTR2—narcolepsy	0.000799	0.00183	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HCRTR1—narcolepsy	0.000799	0.00183	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.000793	0.00182	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000781	0.00179	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000781	0.00179	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—P2RY11—narcolepsy	0.000771	0.00176	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HCRT—narcolepsy	0.000748	0.00171	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000743	0.0017	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000743	0.0017	CbGpPWpGaD
Loperamide—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00074	0.00169	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—HRH3—narcolepsy	0.00074	0.00169	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—PENK—narcolepsy	0.000734	0.00168	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—HCRT—narcolepsy	0.000722	0.00165	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.000718	0.00164	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—HRH3—narcolepsy	0.000718	0.00164	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—TAC1—narcolepsy	0.000704	0.00161	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—NPS—narcolepsy	0.000704	0.00161	CbGpPWpGaD
Loperamide—POMC—GPCR downstream signaling—HTR2A—narcolepsy	0.000687	0.00157	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.000675	0.00154	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.000675	0.00154	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—PENK—narcolepsy	0.000667	0.00153	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HCRT—narcolepsy	0.000656	0.0015	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000655	0.0015	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—P2RY11—narcolepsy	0.000652	0.00149	CbGpPWpGaD
Loperamide—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000649	0.00148	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—PENK—narcolepsy	0.000644	0.00147	CbGpPWpGaD
Loperamide—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000634	0.00145	CbGpPWpGaD
Loperamide—POMC—Signaling by GPCR—HTR2A—narcolepsy	0.000624	0.00143	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—TRH—narcolepsy	0.000624	0.00143	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—TAC1—narcolepsy	0.000613	0.0014	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—NPS—narcolepsy	0.000613	0.0014	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00061	0.0014	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.000603	0.00138	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—NPS—narcolepsy	0.000595	0.00136	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—TAC1—narcolepsy	0.000595	0.00136	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—PENK—narcolepsy	0.000584	0.00134	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—TRH—narcolepsy	0.000567	0.0013	CbGpPWpGaD
Loperamide—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000556	0.00127	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HCRT—narcolepsy	0.000554	0.00127	CbGpPWpGaD
Loperamide—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000548	0.00125	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—TRH—narcolepsy	0.000547	0.00125	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—HRH3—narcolepsy	0.000547	0.00125	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—PENK—narcolepsy	0.000544	0.00124	CbGpPWpGaD
Loperamide—CALM3—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000542	0.00124	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HCRTR2—narcolepsy	0.000538	0.00123	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HCRTR1—narcolepsy	0.000538	0.00123	CbGpPWpGaD
Loperamide—CALM2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000525	0.0012	CbGpPWpGaD
Loperamide—CALM1—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—narcolepsy	0.000525	0.0012	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—P2RY11—narcolepsy	0.00052	0.00119	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—TRH—narcolepsy	0.000497	0.00114	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HRH3—narcolepsy	0.000497	0.00114	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—PENK—narcolepsy	0.000494	0.00113	CbGpPWpGaD
Loperamide—CALM3—Immune System—SOCS2—narcolepsy	0.000486	0.00111	CbGpPWpGaD
Loperamide—CALM1—Cardiac Hypertrophic Response—TNF—narcolepsy	0.000486	0.00111	CbGpPWpGaD
Loperamide—CALM2—Cardiac Hypertrophic Response—TNF—narcolepsy	0.000486	0.00111	CbGpPWpGaD
Loperamide—OPRD1—GPCR ligand binding—HTR2A—narcolepsy	0.000483	0.0011	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—HRH3—narcolepsy	0.00048	0.0011	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HCRTR1—narcolepsy	0.000472	0.00108	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HCRTR2—narcolepsy	0.000472	0.00108	CbGpPWpGaD
Loperamide—CALM2—Immune System—SOCS2—narcolepsy	0.000471	0.00108	CbGpPWpGaD
Loperamide—CALM1—Immune System—SOCS2—narcolepsy	0.000471	0.00108	CbGpPWpGaD
Loperamide—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00047	0.00107	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—TRH—narcolepsy	0.000463	0.00106	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—P2RY11—narcolepsy	0.000456	0.00104	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—TAC1—narcolepsy	0.000453	0.00104	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—NPS—narcolepsy	0.000453	0.00104	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000445	0.00102	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HCRT—narcolepsy	0.000442	0.00101	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HRH3—narcolepsy	0.000436	0.000997	CbGpPWpGaD
Loperamide—CALM3—Downstream signaling in naïve CD8+ T cells—TNF—narcolepsy	0.000434	0.000994	CbGpPWpGaD
Loperamide—OPRK1—GPCR ligand binding—HTR2A—narcolepsy	0.000423	0.000969	CbGpPWpGaD
Loperamide—CALM1—Downstream signaling in naïve CD8+ T cells—TNF—narcolepsy	0.00042	0.000962	CbGpPWpGaD
Loperamide—CALM2—Downstream signaling in naïve CD8+ T cells—TNF—narcolepsy	0.00042	0.000962	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TRH—narcolepsy	0.00042	0.000961	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HCRTR2—narcolepsy	0.000418	0.000956	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HCRTR1—narcolepsy	0.000418	0.000956	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—TAC1—narcolepsy	0.000412	0.000942	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—NPS—narcolepsy	0.000412	0.000942	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000406	0.000928	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HCRTR1—narcolepsy	0.000404	0.000925	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HCRTR2—narcolepsy	0.000404	0.000925	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HCRTR2—narcolepsy	0.000404	0.000925	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HCRTR1—narcolepsy	0.000404	0.000925	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—P2RY11—narcolepsy	0.000403	0.000923	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000399	0.000912	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000399	0.000912	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—TAC1—narcolepsy	0.000398	0.00091	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—NPS—narcolepsy	0.000398	0.00091	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—PENK—narcolepsy	0.000394	0.000901	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—P2RY11—narcolepsy	0.00039	0.000893	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—P2RY11—narcolepsy	0.00039	0.000893	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HCRT—narcolepsy	0.000387	0.000886	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—P2RY11—narcolepsy	0.000385	0.000881	CbGpPWpGaD
Loperamide—CALM3—Alzheimers Disease—TNF—narcolepsy	0.000376	0.000861	CbGpPWpGaD
Loperamide—POMC—Signaling Pathways—HTR2A—narcolepsy	0.000369	0.000844	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HRH3—narcolepsy	0.000368	0.000843	CbGpPWpGaD
Loperamide—CALM2—Alzheimers Disease—TNF—narcolepsy	0.000364	0.000833	CbGpPWpGaD
Loperamide—CALM1—Alzheimers Disease—TNF—narcolepsy	0.000364	0.000833	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—TAC1—narcolepsy	0.000361	0.000826	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—NPS—narcolepsy	0.000361	0.000826	CbGpPWpGaD
Loperamide—OPRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000358	0.000819	CbGpPWpGaD
Loperamide—CALM2—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000346	0.000793	CbGpPWpGaD
Loperamide—CALM1—MicroRNAs in cardiomyocyte hypertrophy—TNF—narcolepsy	0.000346	0.000793	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—PENK—narcolepsy	0.000345	0.00079	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CHKB—narcolepsy	0.000344	0.000788	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HCRT—narcolepsy	0.000343	0.000785	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000336	0.000769	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—NPS—narcolepsy	0.000336	0.000769	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CHKB—narcolepsy	0.000335	0.000767	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TRH—narcolepsy	0.000335	0.000766	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HCRT—narcolepsy	0.000332	0.000759	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HCRT—narcolepsy	0.000332	0.000759	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HCRT—narcolepsy	0.000327	0.000749	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CHKB—narcolepsy	0.000324	0.000742	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CHKB—narcolepsy	0.000324	0.000742	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—PENK—narcolepsy	0.000306	0.0007	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—TAC1—narcolepsy	0.000305	0.000698	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—NPS—narcolepsy	0.000305	0.000698	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—PENK—narcolepsy	0.000296	0.000677	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—PENK—narcolepsy	0.000296	0.000677	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TRH—narcolepsy	0.000294	0.000672	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HRH3—narcolepsy	0.000294	0.000672	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—PENK—narcolepsy	0.000292	0.000668	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CHKB—narcolepsy	0.000292	0.000667	CbGpPWpGaD
Loperamide—ABCB1—Allograft Rejection—TNF—narcolepsy	0.000285	0.000652	CbGpPWpGaD
Loperamide—OPRD1—GPCR downstream signaling—HTR2A—narcolepsy	0.000273	0.000624	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TRH—narcolepsy	0.00026	0.000595	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HRH3—narcolepsy	0.000257	0.000589	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CHKB—narcolepsy	0.000254	0.000581	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TRH—narcolepsy	0.000252	0.000575	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TRH—narcolepsy	0.000252	0.000575	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TRH—narcolepsy	0.000248	0.000568	CbGpPWpGaD
Loperamide—OPRD1—Signaling by GPCR—HTR2A—narcolepsy	0.000248	0.000567	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HCRTR2—narcolepsy	0.000247	0.000565	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HCRTR1—narcolepsy	0.000247	0.000565	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—NPS—narcolepsy	0.000243	0.000557	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—TAC1—narcolepsy	0.000243	0.000557	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CHKB—narcolepsy	0.000239	0.000548	CbGpPWpGaD
Loperamide—OPRK1—GPCR downstream signaling—HTR2A—narcolepsy	0.000239	0.000547	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HCRTR2—narcolepsy	0.000239	0.000546	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HCRTR1—narcolepsy	0.000239	0.000546	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HCRTR2—narcolepsy	0.000239	0.000546	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HCRTR1—narcolepsy	0.000239	0.000546	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—P2RY11—narcolepsy	0.000238	0.000545	CbGpPWpGaD
Loperamide—CYP2B6—Metabolism—CPT1B—narcolepsy	0.000234	0.000536	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—P2RY11—narcolepsy	0.000231	0.000528	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—P2RY11—narcolepsy	0.000231	0.000528	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HRH3—narcolepsy	0.000228	0.000522	CbGpPWpGaD
Loperamide—CALM3—Metabolism—CPT1B—narcolepsy	0.000228	0.000521	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HRH3—narcolepsy	0.000221	0.000505	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HRH3—narcolepsy	0.000221	0.000505	CbGpPWpGaD
Loperamide—CALM1—Metabolism—CPT1B—narcolepsy	0.00022	0.000504	CbGpPWpGaD
Loperamide—CALM2—Metabolism—CPT1B—narcolepsy	0.00022	0.000504	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000219	0.000501	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HRH3—narcolepsy	0.000218	0.000498	CbGpPWpGaD
Loperamide—OPRK1—Signaling by GPCR—HTR2A—narcolepsy	0.000217	0.000497	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—TAC1—narcolepsy	0.000213	0.000488	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—NPS—narcolepsy	0.000213	0.000488	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000212	0.000485	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-DQA1—narcolepsy	0.000212	0.000485	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000205	0.000469	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HCRT—narcolepsy	0.000203	0.000464	CbGpPWpGaD
Loperamide—OPRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000202	0.000463	CbGpPWpGaD
Loperamide—CYP2C8—Metabolism—CPT1B—narcolepsy	0.000198	0.000454	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000198	0.000453	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-DQB1—narcolepsy	0.000198	0.000453	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HCRT—narcolepsy	0.000196	0.000449	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HCRT—narcolepsy	0.000196	0.000449	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—TAC1—narcolepsy	0.000189	0.000432	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—NPS—narcolepsy	0.000189	0.000432	CbGpPWpGaD
Loperamide—OPRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000184	0.00042	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—NPS—narcolepsy	0.000183	0.000418	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—TAC1—narcolepsy	0.000183	0.000418	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—NPS—narcolepsy	0.000183	0.000418	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—TAC1—narcolepsy	0.000183	0.000418	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—PENK—narcolepsy	0.000181	0.000413	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—TAC1—narcolepsy	0.00018	0.000412	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—NPS—narcolepsy	0.00018	0.000412	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—PENK—narcolepsy	0.000175	0.0004	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—PENK—narcolepsy	0.000175	0.0004	CbGpPWpGaD
Loperamide—ABCB1—Metabolism—CPT1B—narcolepsy	0.000173	0.000395	CbGpPWpGaD
Loperamide—CYP2D6—Metabolism—CPT1B—narcolepsy	0.000163	0.000372	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CHKB—narcolepsy	0.000157	0.000358	CbGpPWpGaD
Loperamide—CALM3—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000156	0.000356	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TRH—narcolepsy	0.000154	0.000351	CbGpPWpGaD
Loperamide—CALM2—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000151	0.000345	CbGpPWpGaD
Loperamide—CALM1—Adaptive Immune System—HLA-DRB1—narcolepsy	0.000151	0.000345	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TRH—narcolepsy	0.000149	0.00034	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TRH—narcolepsy	0.000149	0.00034	CbGpPWpGaD
Loperamide—OPRD1—Signaling Pathways—HTR2A—narcolepsy	0.000146	0.000335	CbGpPWpGaD
Loperamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000141	0.000322	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HRH3—narcolepsy	0.000135	0.000308	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DQA1—narcolepsy	0.000133	0.000304	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HRH3—narcolepsy	0.00013	0.000298	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HRH3—narcolepsy	0.00013	0.000298	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DQA1—narcolepsy	0.000128	0.000294	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DQA1—narcolepsy	0.000128	0.000294	CbGpPWpGaD
Loperamide—OPRK1—Signaling Pathways—HTR2A—narcolepsy	0.000128	0.000294	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DQB1—narcolepsy	0.000124	0.000284	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DQB1—narcolepsy	0.00012	0.000275	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DQB1—narcolepsy	0.00012	0.000275	CbGpPWpGaD
Loperamide—CALM3—Signaling by GPCR—HTR2A—narcolepsy	0.000114	0.00026	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—TAC1—narcolepsy	0.000112	0.000255	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—NPS—narcolepsy	0.000112	0.000255	CbGpPWpGaD
Loperamide—CALM1—Signaling by GPCR—HTR2A—narcolepsy	0.00011	0.000252	CbGpPWpGaD
Loperamide—CALM2—Signaling by GPCR—HTR2A—narcolepsy	0.00011	0.000252	CbGpPWpGaD
Loperamide—OPRM1—Signaling Pathways—HTR2A—narcolepsy	0.000108	0.000248	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—TAC1—narcolepsy	0.000108	0.000247	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—NPS—narcolepsy	0.000108	0.000247	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—NPS—narcolepsy	0.000108	0.000247	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—TAC1—narcolepsy	0.000108	0.000247	CbGpPWpGaD
Loperamide—CYP3A4—Metabolism—CPT1B—narcolepsy	0.000106	0.000243	CbGpPWpGaD
Loperamide—CALM3—Immune System—HLA-DRB1—narcolepsy	9.45e-05	0.000216	CbGpPWpGaD
Loperamide—CALM2—Immune System—HLA-DRB1—narcolepsy	9.14e-05	0.000209	CbGpPWpGaD
Loperamide—CALM1—Immune System—HLA-DRB1—narcolepsy	9.14e-05	0.000209	CbGpPWpGaD
Loperamide—CALM3—Signaling Pathways—HTR2A—narcolepsy	6.71e-05	0.000154	CbGpPWpGaD
Loperamide—CALM2—Signaling Pathways—HTR2A—narcolepsy	6.49e-05	0.000149	CbGpPWpGaD
Loperamide—CALM1—Signaling Pathways—HTR2A—narcolepsy	6.49e-05	0.000149	CbGpPWpGaD
